Cargando…
Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy
SIMPLE SUMMARY: Treatment of pregnant cancer patients should adhere as much as possible to standard treatment protocols in order to safeguard maternal prognosis. The use of Granulocyte colony-stimulating factor (G-CSF) can be indicated for dose dense chemotherapy in high risk breast cancer patients...
Autores principales: | Berends, Claudia, Maggen, Charlotte, Lok, Christianne A. R., van Gerwen, Mathilde, Boere, Ingrid A., Wolters, Vera E. R. A., Van Calsteren, Kristel, Segers, Heidi, van den Heuvel-Eibrink, Marry M., Painter, Rebecca C., Gziri, Mina Mhallem, Amant, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001066/ https://www.ncbi.nlm.nih.gov/pubmed/33802196 http://dx.doi.org/10.3390/cancers13061214 |
Ejemplares similares
-
Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
por: Maggen, Charlotte, et al.
Publicado: (2019) -
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
por: van Gerwen, Mathilde, et al.
Publicado: (2021) -
Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review
por: Han, Sileny N, et al.
Publicado: (2012) -
Pregnancy and Cancer: the INCIP Project
por: Maggen, Charlotte, et al.
Publicado: (2020) -
Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy
por: Vandenbroucke, Tineke, et al.
Publicado: (2020)